- December 15, 2020
Industrializing Personalized Therapeutics: Can You Really “Mass Customize” Patient-specific Pharmaceuticals?
Publication: PM360
In the first of a three-series podcast with Vineti, CEO and Founder Amy DuRoss discusses the rapid growth of cell and gene therapies and whether…
- November 9, 2020
Vineti Is Streamlining the Supply Chain for Personalized Therapies
Publication: PM360
- October 13, 2020
Vineti Extends Series C Funding Round to $68M with an Expanded Investor Coalition
Publication: Globe Newswire
- August 25, 2020
OncoBay Clinical and Vineti form strategic alliance to deliver integrated clinical trial solutions and supply chain automation for cell and gene therapies
Publication: Globe Newswire
- August 11, 2020
Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing debilitating conditions
Publication: Globe Newswire
- July 29, 2020
Vineti and EVERSANA™ form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine
Publication: PR Newswire
- July 28, 2020
10 Companies to Watch on the LeadSift List of Resilient Companies
Publication: crunchbase
- June 16, 2020
Vineti launches new Alliance Network — and announces a collaboration with Mavens — to deliver integrated solutions for cell and gene therapies
Publication: GlobeNewswire
We use cookies for analytics, marketing purposes, and to improve our site. You agree to our use of cookies by clicking yes. To find out more, including how to change your settings, see our privacy policy for details.